Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Accenture
Cipla
Fish and Richardson
Johnson and Johnson
Merck
AstraZeneca
Queensland Health
Express Scripts
Cantor Fitzgerald

Generated: February 23, 2018

DrugPatentWatch Database Preview

LOPRESSOR Drug Profile

« Back to Dashboard

US Patents and Regulatory Information for LOPRESSOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704-001 Mar 30, 1984 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis LOPRESSOR metoprolol fumarate TABLET, EXTENDED RELEASE;ORAL 019786-003 Dec 27, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR HCT hydrochlorothiazide; metoprolol tartrate TABLET;ORAL 018303-001 Dec 31, 1984 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis LOPRESSOR metoprolol fumarate TABLET, EXTENDED RELEASE;ORAL 019786-001 Dec 27, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis LOPRESSOR metoprolol fumarate TABLET, EXTENDED RELEASE;ORAL 019786-002 Dec 27, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis LOPRESSOR metoprolol fumarate TABLET, EXTENDED RELEASE;ORAL 019786-004 Dec 27, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR HCT hydrochlorothiazide; metoprolol tartrate TABLET;ORAL 018303-003 Dec 31, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR HCT hydrochlorothiazide; metoprolol tartrate TABLET;ORAL 018303-002 Dec 31, 1984 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for LOPRESSOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704-001 Mar 30, 1984 ➤ Sign Up ➤ Sign Up
Novartis LOPRESSOR metoprolol fumarate TABLET, EXTENDED RELEASE;ORAL 019786-004 Dec 27, 1989 ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Novartis LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704-001 Mar 30, 1984 ➤ Sign Up ➤ Sign Up
Novartis LOPRESSOR metoprolol fumarate TABLET, EXTENDED RELEASE;ORAL 019786-003 Dec 27, 1989 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Accenture
Mallinckrodt
Express Scripts
Dow
Johnson and Johnson
Farmers Insurance
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot